Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary
November 5, 2024
Earnings Call Speaker Segments
Michael Critelli
executiveThanks, and good morning to all of you; we’re glad you could join Flotek’s conference call covering results for the third quarter of 2024. With me today are Ryan Ezell, our Chief Executive Officer, and Bond Clement, our Chief Financial Officer. To start, we’ll share prepared comments about how the business performed and what our financial results looked like during the third quarter of 2024, along with our revised guidance covering the entire 2024 year; after that, we’ll take any questions you may have. Yesterday afternoon, Flotek issued its press release containing financial and operating results for the third quarter of 2024. An updated Q3 earnings presentation has also been posted, and we’ll refer to it during today’s call; both items are available in the investor relations portion of our website. Beyond that, a webcast is happening for today’s call, and once this call ends, a replay can be accessed through our website. Be aware that anything said today about projections or expectations for events in the future constitutes forward looking statements. Such forward looking statements carry a variety of risks and uncertainties, a great many of which lie outside our control. Actual results could differ materially from what we currently expect because of these risks and uncertainties. Listeners should examine our earnings release as well as the risk factors described in the documents we file with SEC. Kindly look at the reconciliation included in the earnings press release and corporate presentation, since management will discuss non-GAAP metrics during this call; with that, I’ll hand things over to Ryan Ezell, our CEO.
Ryan Ezell
executiveThanks, Mike, and good morning, everyone. We appreciate your interest in Flotek and for being here today as we go over our operational and financial results for the third quarter of 2024. I'm happy with how we executed our overall strategy this quarter, but we're staying intensely focused on lifting our performance so we can grow market share and profitability in both of our complementary business segments, and we're pushing the organization to finish our strongest year since 2017. The remaining months of this year will require hard work. We have faith in our team's capacity to deliver despite market headwinds and to keep up the pattern of posting solid results and the value creation for Flotek shareholders that comes with it. With that said, I'd like to go to slide 5 and cover our key highlights for the quarter, which Bond will walk through in detail shortly. Against a backdrop of softer North American Oil Field Services activity, we managed to increase total revenue 5% versus the third quarter of 2023 and 8% sequentially from the second quarter of 2024, which underscores our strong execution and the ongoing progress we've made in taking market share; that's quite an achievement given that active frac fleet counts have fallen over 14% from the peak of the first quarter 2024. Revenues in our data analytics segment rose 30% in the third quarter, as shown on slide 7, with data as a service revenue up 40% sequentially. After the EPA's approval of our JP3 analyzer in mid-July 2024, we recognized our first revenues for flare monitoring in August and September, which made up 25% of total quarterly segment revenues. Revenue from our chemistry technology segment was up 7% in the third quarter. Our continued revenue growth in this segment, even with a declining frac fleet market, is clear proof that we're gaining market share through our differentiated chemistry technology solutions. We achieved significant year over year gains in virtually all profitability metrics, producing net income of $2.5 million and adjusted EBITDA of $4.8 million, which represent a year over year increase of 97% and 43% respectively; this marks Flotek's 5th consecutive quarter of net income and 8th consecutive quarter of improvement in adjusted EBITDA. Because of this, we're raising our adjusted EBITDA guidance for the second time this year. On a trailing 12 month basis, as shown on slide 8. Flotek has delivered almost $25 million of improvement in adjusted EBITDA. Lastly, we cut borrowings outstanding under the asset base loan by 81%, or $6.1 million, compared to year end of 2023, and most importantly, all of these achievements came with zero recordable and lost time incidents. I want to pause for a second and express appreciation to every one of our team members for the effort they put in and their dedication to safety and to serving customers well, which made these remarkable results possible; and my enthusiasm about what lies ahead for Flotek hasn't faded, and I feel we're in a strong spot to grab additional market share. We remain a leader in this industry, pushing innovation forward and providing distinctive chemistry and data offerings that fit what our customers specifically require. By using chemistry as the shared foundation for value creation, we aim to build answers for tomorrow's industry challenges before demand for them arises. Flotek will stay ahead when it comes to innovation and cross-disciplinary progress as we introduce new technologies into the market by merging data with chemistry solutions, Flotek is developing AI powered reservoir modeling to tackle water inhibition effects, encourage preferential microfluid behavior within nanopore environments, and enhance the ultimate recovery of hydrocarbons from every asset. By using real time data measurements, we're opening up the possibility of deploying predictive analytics to manage our customers' assets in a holistic way and maximize their return on invested capital; we anticipate ongoing growth of our data as a service model as we roll out our next generation near infrared raman and aqueous environment measurement systems, which unlocks substantial upstream and downstream market opportunities if we expect the business to keep growing moving forward. As part of our dedication to staying at the leading edge of innovation, in July we announced that the EPA approved our JP3 system regarding recently enacted flare regulations. You can view a photo of our new flare monitoring cart currently at a location on slide 10. This cutting edge optical instrument is built to measure net heating values and flare gasses with precision, and it's the first one approved as an alternative method under the new rules. Per the EPA, more than 55,000 existing players exist in the United States, and they're anticipated to fall under monitoring regulations by 2028 and this approval puts Flotek in position for growth in this new upstream space; we've already gotten many orders, with 11 units delivered so far, an increase from three that we referenced on our August call. Most flare application revenues so far have come via rental and service contracts, which means a recurring revenue stream. In addition, our upstream custody transfer use cases keep growing into field trials, with three active units total during the third quarter, and another eight committed units brought on so far in the fourth quarter, we're set to obtain full certification for field utilization by year end. Our capacity to track hydrocarbon composition and quality in real time, with readings captured every five seconds will open up a new market for Flotek to step into during 2025 and afterward. This groundbreaking tool delivers a higher degree of visibility and a reduction of enterprise risk for wells in production that the oil and gas sector has not seen until now. Looking ahead, we anticipate that need for oil and gas will grow across the coming 10 years, with additional requirements through 2045. For the first time in almost 20 years, electricity demand in the U.S. is projected to rise 15% by 2030, yet natural gas is expected to supply most of that added demand. We anticipate continued growth of the worldwide economy will keep generating considerable need for every type of energy, which will drive greater service intensity across the sector. Turning to the rest of 2024, our focus stays on growing revenue, expanding market share, achieving cost efficiency gains, and building shareholder value, since we are positioned well to seize opportunities both at home and abroad. We have confidence that our growing range of services puts us in a position to provide distinctive and superior solutions for many of the toughest challenges in our industry, all while optimizing our customers' value chain. I'll now hand the call to Bond for the key financial highlights.
Bond Clement
executiveThanks, Ryan. And thanks to all of you for being with us; this morning — yesterday afternoon, rather — we announced solid results for Q3. Looking at the income statement, we delivered quarter-over-quarter gains in revenue, net income, and adjusted EBITDA, despite softer industry fundamentals; looking at the balance sheet, we grew working capital and reduced debt. Our ABL balance on September 30th had fallen 75% versus the close of Q2, as we tapped a 12% enhancement in DSOs over the quarter along with $5 million of operating cash flow to bring down the line. Briefly on a handful of particular figures — I'll be pointing to the slides in the deck posted to our site yesterday afternoon. Slide 5 lays out some of what we accomplished in Q3: revenues, net income, and adjusted EBITDA all rose relative to Q3 of the prior year. Net income almost doubled, while adjusted EBITDA climbed more than 40% against the same quarter a year earlier. Turning to revenue for the quarter, total revenues came in at $49.7 million, an 8% sequential gain, driven by robust growth in revenue from our data analytics segment, plus a 19% rise in related party chemistry revenue. External customer chemistry revenues did decline quarter over quarter. Even so, they remain up 3% across the first nine months compared with last year; note that three large customers hit operational delays in September, which pushed some external chemistry sales into Q4. We absolutely expect external chemistry revenues to rebound strongly in Q4. For Q3, gross profit was unchanged from Q2. In percentage terms, gross profit margin declined roughly 150 basis points quarter over quarter, driven by lower external chemistry revenues, which affects our product mix, and by reduced revenue tied to the order shortfall penalty under our long-term supply agreement, itself a consequence of sequential growth in our related party business. Partly countering these factors was our data analytics segment, which delivered a significant gross profit contribution in Q3. As slide 7 shows, data analytics gross profit reached $1.2 million in this year's third quarter, up 88% from Q2. Data analytics gross margin was 44% for the quarter, a 47% sequential improvement as we expanded recurring revenue during the period; margins like these are exactly why we're so enthusiastic about the prospects for continued revenue growth in this segment that Ryan mentioned earlier. Further down the income statement, we had a terrific quarter when it comes to cutting overhead. During Q3, SG&A expenses came in at $5.7 million, which represents a 12% gain over Q3 of the prior year and a 9% improvement on a sequential basis. For SG&A and cost across the opening nine months, we're now 15% lower than a year ago, which has generated more than $3 million in savings — approximately 50% of net income for the year to date. This remains an area where we'll keep applying our strongest focus on making improvements. Turning to slide 8, adjusted EBITDA for the quarter rose to $4.8 million. Bear in mind that we achieved 9% sequential growth in adjusted EBITDA even though revenue tied to the order shortfall penalty under our supply agreement fell 19%, or $1.6 million, versus the second quarter. Regarding the balance sheet as of September 30th, we had drawn $1.4 million under the ABL. As of September 30th, our debt to trailing 12 month adjusted EBITDA stood at less than 0.1 times. On our updated 2024 guidance, this marks the second occasion this year we are raising it, driven by the robust operational results we've delivered so far and what we foresee for Q4. Adjusted EBITDA is now projected by us to land between $16.5 million and $18.5 million, representing a 35% rise at the midpoint relative to the $10 million to $16 million range we initially gave for 2024. To phrase it differently, the bottom of the range we're now guiding to sits above the top of the range we originally provided. According to our present projections, 2024 adjusted gross profit margin should land somewhere between 20% and 22%, a very favorable comparison against our 2023 adjusted gross profit margin of 15%. To wrap up, we delivered strong third quarter figures that extend a stretch of multiple back-to-back quarters of financial and operational momentum. We're enthusiastic about what we achieved across the first three quarters, and we look forward to finishing 2024 on a strong note. Should we reach the midpoint of our updated guidance, that would mean a $16 million gain in adjusted EBITDA compared with 2023, plus a $26 million gain compared with 2022. I'll now hand the call back to Ryan for his closing remarks.
Ryan Ezell
executiveThank you, Bond. We're enthusiastic about what's left of 2024, since tremendous growth potential exists for us in both the chemistry and data analytics segments, even with the market headwinds that persist. In our view, Flotek remains a compelling investment opportunity. The growing opportunities inside our data analytics segment serve as a strong catalyst for future revenue of profitability, growth. Our third quarter results deliver profitability, and as a collaborative partner of choice for chemistry and data solutions, we remain positioned for sustained growth. The progress we've made makes me proud, and I'm confident in our ability to keep executing going forward. We appreciate the continued support of all of our stakeholders, and we hope you share our excitement regarding the future of Flotek, and we look forward to reporting further progress. Operator, we're now ready to take questions.
Jeff Grampp
analystI'd like to kick things off regarding the flare market, because there have been some positive developments there. First off, I'm wondering whether you could address the sales approach that upstream clients tend to favor — specifically, leasing as opposed to purchasing. Beyond that, I'm also interested in how concentrated the customer base is. Is it a handful of buyers who are truly committing fully to this? Or rather a wider array of customers who are merely testing things out, with room to ramp up adoption down the road? Hearing your thoughts on each of those would be excellent. Thank you.
Ryan Ezell
executiveSure. Regarding the commercial structure, it's clear that our preference leans toward the rental service agreement arrangement, and as we noted previously, that's the format we direct most business toward. A handful of clients are pursuing what we'd describe as round-the-clock flare monitoring — meaning they aren't simply showing up to track emissions during the 2-week window mandated under EPA rules. Because of that, they're considering a possible capital acquisition over the longer horizon, and in those cases we'd have a lengthy contract set up covering the monitoring software and related items. That said, at present we're steering things toward the favored full rental service approach, whether that involves handling several wells simultaneously or just a single test. Looking ahead regarding customer concentration types, at the outset we had, I'd estimate, between 5 and 10 clients genuinely driving things forward. Those are the ones chiefly concerned with sustainability and environmental performance overall, and we've achieved solid results. That said, I can tell you the mix of customers is broadening rapidly. My guess is that given what's happening now politically, certain parties pulled back, simply wanting to observe how things unfold. I doubt that changes the reality that testing will keep happening. We recently spoke with the EPA, and what they anticipate is that oversight and rules will keep progressing just as they have been. So we're likely — we anticipate somewhat more momentum toward the close of this week compared with our current position — yet our customer variety has been excellent up to now.
Jeff Grampp
analystThose details are much appreciated, Ryan. For my follow-up regarding costs, you've kept delivering really strong results in that area, especially on SG&A. I'm curious whether at some stage it starts making sense to expand that line. Since EBITDA margins are rising and ought to keep rising, it appears, and considering the growth chances you have involving items such as JP3, how are you all thinking about carrying on the outstanding outcomes you've achieved on the cost front versus sort of putting money back into growing the business.
Bond Clement
executiveHey, Jeff, this is Bond, and I appreciate the question. Yes, we are considering possibly bringing on additional staff in light of the demand we are witnessing on the flare marketing side. So these would probably be JP3 individuals who would appear in the cost of goods sold section of the income statement rather than SG&A, though nothing, nothing at this point in time. We are simply sort of watching the demand to determine what we can accomplish with the current employee group, but likely headcount could tick up somewhat in the coming year. Still, again, because of the revenue growth we anticipate, on a percentage of revenue basis, we would anticipate SG&A to keep declining.
Ryan Ezell
executiveYeah, and I think to give you a bit more detail from my end on that, Jeff, we began examining it from an SG&A perspective. It probably won't be a major increase. It would be more on the direct cost side for field delivery as we develop that service model, and there's no question that we're likely looking at a fair amount of CapEx going into the data as a service business to stay ahead of the demand curve that we're going to see coming in 2025.
Gerry Sweeney
analystI'd like to remain on the data topic. I'm simply curious about the pipeline. What's your view of the sales cycle? What length of time will be needed to, perhaps, push deals over the line? I believe you provided — Ryan shared some specifics on that, particularly regarding the election — but I'm just wondering broadly. And then, well, once regulation sort of kicks in, how would that affect the sales cycle too, especially as we progress as those become somewhat more established next year and the year after.
Ryan Ezell
executiveHonestly, there are several positive points worth adding here to give more context around Gerry. When we examine our figures in the service side of the business, specifically within data analytics, our focus really centers on what the pipeline holds. We tend to split those into two groups: what was our established primary operation, dealing with reid vapor pressure monitoring, transmix, crude monitoring, and so on, and the CAGR coming from the market in those segments, which generally involve a longer sales cycle. We're talking about somewhere between 9 and 12 months, and typically they align with CapEx plans while being treated as OpEx expense. As we've begun building what I'd call these emerging markets in monitoring flare, gas, and our chain of custody that I referenced earlier, which is an exciting new area. These markets, along with their size, keep growing, and they present compelling opportunities for the company's growth, since sales cycles in a government regulated area are clearly much quicker. As people will need to begin satisfying the requirements, we're watching these shift from 9 to 12 months down to weeks at a time during the pursuit, sometimes under a month, and so that's creating a tremendous opportunity in a market whose true size we're still beginning to grasp, which, you know, if you simply run some rough calculations on 55,000 active wells, and if we consider the chain of custody side, likely more than 100,000 wells to monitor, you can begin to see the potential there. But returning to the pipeline, I believe in our core business, we've observed roughly 15% or 20% growth in opportunities for ‘25, and it's growing by double digit percentages each month on the upstream pieces, when you consider the size of what's arriving with flare and the chain of custody side; and as we look ahead into ‘25 and ‘26, we're sort of working through a low, medium and high range regarding the potential sizes of these markets, and how we approach making sure we reinvest the right CapEx so we capture all the growth potential there.
Bond Clement
executiveHi Gerry, this is Bond. I just wanted to follow up briefly and consider how fast sales are moving for the flare monitoring. We received the EPA regulations, and approval came around mid-July. In August, revenue reached roughly $100,000, while September brought in about $600,000, so it is truly beginning to build momentum.
Gerry Sweeney
analystRegarding that topic. And what I'd like to move on to now is, I believe you mentioned you had, and quite a bit of detail was shared there. So I'm sorry if I've got this incorrect. 3 units, I think during the quarter, and you're aiming to reach 11 units?
Ryan Ezell
executiveFinish the question then I will finish it up.
Gerry Sweeney
analystNo, I just want to confirm — that's regarding flare gas monitoring, going from 3 units up to 11 units. And the figures Bond just provided kind of suggest flare gas is beginning to gain traction and is making a real difference in the fourth quarter; we ought to see a real difference as additional units keep coming on board. Now, I realize there are likely some distinctions between renting and selling capital equipment, but perhaps we could talk about that.
Ryan Ezell
executiveYeah, so let me be clear about those figures — the 3 we talked about during our August earnings call for Q2 were in location, and that count went up from 3 to 11, and by this Friday it'll actually hit 12 that are active in flare monitoring, and we're expecting that to keep climbing through the quarter. We also brought up our chain of custody applications, which is a totally separate thing where we're examining hydrocarbon composition of flowing — for that one we had 3 field trials going. We'll bring on another 8 units in Q4 and keep driving that figure higher. So it's a pretty exciting story. I'd say 3 quarters back we were discussing monitoring field gas flare monitoring, chain of custody, and today those use cases are live and expanding. So there's a lot of potential in those areas.
Gerry Sweeney
analystThis question has a bit of nuance to it. Regarding flare monitoring along with chain of custody — are those progressing as planned, or are they expanding more quickly than you might have expected half a year ago?
Ryan Ezell
executiveThat's what I'd say. Regarding the chain — what I actually meant is that flare monitoring is more or less where it should be, given how anyone would react to the geopolitical situation surrounding November 5, correct? Those are the things I watch for — as we told you before, we anticipate they'll shift into an even higher gear during the second half of the year, both on deliveries and on flare; and I'd say the chain of custody element is likely somewhat further along than our expectations, since there are numerous components tied to it concerning what people do with it, how transparent that data is and how it intersects with whether they're focused on the price or paying for the composition of that crude, and so on, versus a composite sample. That's why we're also bringing up certification of the measurement in terms of how the market perceives it, but clearly, at this moment it's ahead of schedule.
Gerry Sweeney
analystYeah, obviously, with the election and all that. Regarding some of the modifications to the rigs, I think flare gas monitoring is performing quite well, given certain market nuances and various developments. It seems to me that it's actually more robust than what I had expected.
Ryan Ezell
executiveYes, and once more, what makes us enthusiastic about this is that, as you know, because of the strong results out in the field, we can connect the monitor, and during some of the testing we've reached as many as three wells within a single day. So up to this point it has performed very effectively.
Josh Jayne
analystMy first question concerns the chemistry segment, which rose 7% versus the prior quarter despite frac count and rig count staying weak. You shared some views regarding electricity demand through 2030, and I won't ask you to forecast that, but perhaps you could describe the current position within the U.S. land cycle, what your customers are saying about the coming couple of quarters, and whether you believe you can keep outperforming, or what reasons might allow that, as you have done across roughly the last 9 to 12 months in chemistry.
Ryan Ezell
executiveYes, for us it remains somewhat like peering into a crystal ball, correct? I'd say we weren't sitting where we are in Q4; my view is that Q4 will be comparatively, let's say, soft for the market as a whole. I believe we've enjoyed some genuinely solid, sticky, transactional dealings with our customer base. And I anticipate an acceleration across our international chemistry markets; therefore I think the chemistry side will deliver a strong quarter. Regarding 2025, our customers tell us that over the upcoming quarters, especially as you approach the middle of the year, operational intensity will strengthen, rising somewhat, yet I still believe everything hinges on the quality of our commodity pricing for natural gas and on how the geopolitical situation sustains the oil price from the demand standpoint. But I'm hopeful, and this is what we're reading in the tea leaves, that Q4 will prove the slower point. You'll begin to notice a modest uptick as we move into 2025 — that's how we see it at present. And I think diversification, with us supplementing part of the North American activity — what we're doing in international markets, in Latin America, in the Middle East — will provide us a bit of extra room to stretch our wings when it comes to outperforming.
Josh Jayne
analystAll right, thank you. That helps. Then perhaps only a single question regarding the income statement — or actually, pardon me, regarding the cash flow statement for Bond. Working capital has grown somewhat across what you could refer to as 9 months. Any views on turning a portion of the AR into cash, simply as we proceed through the coming couple of quarters, and on the reasons we might be in a position to turn more cash into reality than what you have produced up to now. Thanks.
Bond Clement
executiveYes. Keep in mind, Josh, that a significant piece of that working capital increase ties to the order shortfall penalty. Settlement of that order shortfall penalty happens yearly, meaning that receivable merely expands across the year to whatever degree ProFrac fails to buy the necessary quantity of chemistry; therefore that is something over which we lack much control; however, were you to remove the OSP from the working capital change. AR in fact declined across the second quarter, so we are performing fairly well. As I believe I said, DSOs got better by 12% across the quarter once you take out that order shortfall penalty, which sits on payment terms that differ somewhat from those of the remainder of our typical business.
Ryan Ezell
executiveWe appreciate all of you for coming back onto this call. Once more, we remain enthusiastic regarding what lies ahead for Flotek, and the way our company keeps developing involves uniting the combined strengths of our distinctive and inventive chemistry technologies division alongside our growing markets plus data analytics, and we anticipate speaking with you again in Q4. Thanks for spending part of your day with us.
Operator
operatorEveryone, that brings today's conference call to an end. We appreciate your participation, and we ask that you disconnect your lines.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.